Exact Mass: 470.2715
Exact Mass Matches: 470.2715
Found 500 metabolites which its exact mass value is equals to given mass value 470.2715
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Withaferin_A
Withaferin A is a withanolide that is 5,6:22,26-diepoxyergosta-2,24-diene-1,26-dione substituted by hydroxy groups at positions 4 and 27 (the 4beta,5beta,6beta,22R stereoisomer). Isolated from Physalis longifolia, it exhibits cytotoxic activity. It has a role as an antineoplastic agent and an apoptosis inducer. It is a delta-lactone, a 4-hydroxy steroid, an enone, an ergostanoid, a secondary alcohol, a withanolide, a 27-hydroxy steroid, a primary alcohol and an epoxy steroid. Ashwagandha is a popular Ayurvedic herb used as a general tonic, to increase energy and reduce stress. Ashwagandha has not been implicated in causing serum enzyme elevations during therapy, but recently has been implicated in rare cases of clinically apparent liver injury. Withaferin A is a natural product found in Vassobia breviflora, Withania somnifera, and other organisms with data available. A withanolide that is 5,6:22,26-diepoxyergosta-2,24-diene-1,26-dione substituted by hydroxy groups at positions 4 and 27 (the 4beta,5beta,6beta,22R stereoisomer). Isolated from Physalis longifolia, it exhibits cytotoxic activity. Withaferin A is a steroidal lactone isolated from Withania somnifera, inhibits NF-kB activation and targets vimentin, with potent antiinflammatory and anticancer activities. Withaferin A is an inhibitor of endothelial protein C receptor (EPCR) shedding. Withaferin A is a steroidal lactone isolated from Withania somnifera, inhibits NF-kB activation and targets vimentin, with potent antiinflammatory and anticancer activities. Withaferin A is an inhibitor of endothelial protein C receptor (EPCR) shedding.
Withanolide
Withanolides, which are extracted from Withania somnifera, are employed in the treatment of arthritis and are known to be potent inhibitors of angiogenesis, inflammation and oxidative stress. Withanolides can indeed inhibit the activation of NF-κB and NF-κB-regulated gene expression, which could explain their anti-arthritic actions. W. somnifera root powder has suppressive effect on arthritis by reducing amplification and propagation of the inflammatory response, without causing any gastric damage. (PMID: 17475558, 3248848, 17084827).
Withanolide A
Withanolide A is found in herbs and spices. Withanolide A is isolated from Lycium chinense (Chinese boxthorn Isolated from Lycium chinense (Chinese boxthorn). Withanolide A is found in tea and herbs and spices.
Methyl lucidenate F
Methyl lucidenate F is found in mushrooms. Methyl lucidenate F is a constituent of Ganoderma lucidum (reishi).
Ceanothine C
Ceanothine C is found in tea. Ceanothine C is an alkaloid from the root bark of Ceanothus americanus (New Jersey tea
Bazedoxifene
G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03X - Other sex hormones and modulators of the genital system > G03XC - Selective estrogen receptor modulators D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D020847 - Estrogen Receptor Modulators C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D050071 - Bone Density Conservation Agents C1892 - Chemopreventive Agent
Desisobutyrylciclesonide
Withaferin A
DG(2:0/PGF2alpha/0:0)
DG(2:0/PGF2alpha/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/PGF2alpha/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(PGF2alpha/2:0/0:0)
DG(PGF2alpha/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGF2alpha/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/PGF2alpha)
DG(2:0/0:0/PGF2alpha) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(PGF2alpha/0:0/2:0)
DG(PGF2alpha/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/PGE1/0:0)
DG(2:0/PGE1/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/PGE1/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(PGE1/2:0/0:0)
DG(PGE1/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE1/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/PGE1)
DG(2:0/0:0/PGE1) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(PGE1/0:0/2:0)
DG(PGE1/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/PGD1/0:0)
DG(2:0/PGD1/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/PGD1/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(PGD1/2:0/0:0)
DG(PGD1/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD1/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/PGD1)
DG(2:0/0:0/PGD1) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(PGD1/0:0/2:0)
DG(PGD1/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
CID 92044470
Ingenol-5,20-acetonide-3-O-angelate is a natural compound.
5,7alpha-epoxy-6alpha,20alpha-dihydroxy-1-oxowitha-2,24-dienolide
(4beta,17alphaOH,22R)-4,17,27-Trihydroxy1-oxowitha-2,5,24-trienolide
5alpha,14alpha,20alphaF(R)-trihydroxy-1-oxowitha-2,7,24-trienolide|withasomniferol C
(17R,20S,22R)-5beta,6beta-epoxy-4beta,18-dihydroxy-1-oxowitha-2,24-dienolide|18-deacetylwithacnistine
4-Phenylphenacyl ester-(E)-11,17-Octadecadien-9-ynoic acid
(17R)-14,17,20-trihydroxy-22,26-epoxyergosta-2,5,24-triene-1,26-dione|Withanolide J
(17R,20S,22R)-5beta,6beta-epoxy-4beta,16alpha-dihydroxy-1-oxowitha-2,24-dienolide|16-deacetyliochromolide
Baimantuoluoside C
12-deoxywithastramonolide is a withanolide. 12-Deoxywithastramonolide is a natural product found in Withania somnifera and Datura metel with data available. 12-Deoxywithastramonolide is a principle bioactive compound found in ashwagandha (W. somnifera). 12-Deoxywithastramonolide possesses antioxidant and enzyme inhibitory effects[1]. 12-Deoxywithastramonolide is a principle bioactive compound found in ashwagandha (W. somnifera). 12-Deoxywithastramonolide possesses antioxidant and enzyme inhibitory effects[1].
2beta-(angeloyloxy)-6alpha-(p-anisoyloxy)-4beta-hydroxydauc-8-ene|tunetanin A
(20R,22R)-14alpha,17alpha,19-trihydroxy-1-oxowitha-2,5,24-trien-22,26-olide|cinerolide
6alpha,7alpha-epoxy-5alpha-hydroxy-17alpha-[(1R,4R,5R,7R)-4-hydroxy-4,5-dimethyl-3-oxo-2-oxabicyclo[3.2.1]octan-7-yl]androst-2-en-1-one|mandragorolide A
1-methyl-L-proline (4S)-7t-sec-(or iso)butyl-3t-isopropyl-5,8-dioxo-2-oxa-6,9-diaza-1(1,4)-benzena-cycloundecaphan-10c-en-4r-ylamide|Ceanothin C|ceanothine-C
2-(1-oxo-2-hydroxyethyl)-3-hydroxy-5-(3-methyl-2-butenyloxy)-6-(3-methyl-2-butenyl)-6(S)-(3,7-dimethyl-8-oxo-2E,6E-octadienyl)-2,4-cyclohexadien-1-one|coodeanone C
(14S,17R,20S,22R)-14,17,20,22-tetrahydroxy-1-oxoergosta-3,5,24-trien-26-oic acid 22,26-lactone|withacoagulin I
(20R,22R)-14,20alpha,27-trihydroxy-1-oxowitha-3,5,24-trienolide|1-oxo-14,20alphaF,27-trihydroxy-20R,22R-witha-3,5,24-trienolide|14alpha,20alphaF,27-trihydroxy-1-oxo-(22R)-witha-3,5,24-trienolide
1-methyl-L-proline (4S)-3xi-ethyl-7t-isobutyl-3xi-methyl-5,8-dioxo-2-oxa-6,9-diaza-1(1,4)-benzena-cycloundecaphan-10c-en-4r-ylamide|Ceanothin-D|ceanothine-D
Withanolide A
Withanolide A is a withanolide. withanolide A is a natural product found in Withania somnifera, Withania coagulans, and Discopodium penninervium with data available.
3beta,17beta-dihydroxy-14,20-epoxy-1-oxo-(22R)-witha-5,24-dienolide|3beta,17beta-dihydroxy-14,20-epoxy-1-oxo-22R-witha-5,24-dienolide|ajugin|coagulin R
17-hydroxy,27-deoxy-withaferin A|17-hydroxy-27-deoxy withaferin A|17-hydroxy-27-deoxywithaferin A|27-deoxy-17-hydroxywithaferin A
3beta,17beta,20-Trihydroxy-1-oxo-(20R,22R)-witha-5,14,24-trienolide
3-(4-O-acetyl-6-deoxy-beta-galactopyranosyloxy)-19-norpregna-1,3,5(10),20-tetrae-ne
4-desmethoxy-16-dehydrowithangulatin E|withangulatin F
Withanone
Annotation level-1 Withanone is a natural product found in Withania somnifera, Physalis philadelphica, and Discopodium penninervium with data available.
Withaferin A
Withaferin A is a steroidal lactone isolated from Withania somnifera, inhibits NF-kB activation and targets vimentin, with potent antiinflammatory and anticancer activities. Withaferin A is an inhibitor of endothelial protein C receptor (EPCR) shedding. Withaferin A is a steroidal lactone isolated from Withania somnifera, inhibits NF-kB activation and targets vimentin, with potent antiinflammatory and anticancer activities. Withaferin A is an inhibitor of endothelial protein C receptor (EPCR) shedding.
Ala Pro Gln Arg
Ala Pro Arg Gln
Ala Gln Pro Arg
Ala Gln Arg Pro
Ala Arg Pro Gln
Ala Arg Gln Pro
Glu Ile Ile Pro
Glu Ile Leu Pro
Glu Ile Pro Ile
Glu Ile Pro Leu
Glu Leu Ile Pro
Glu Leu Leu Pro
Glu Leu Pro Ile
Glu Leu Pro Leu
Glu Pro Ile Ile
Glu Pro Ile Leu
Glu Pro Leu Ile
Glu Pro Leu Leu
Ile Glu Ile Pro
Ile Glu Leu Pro
Ile Glu Pro Ile
Ile Glu Pro Leu
Ile Ile Glu Pro
Ile Ile Pro Glu
Ile Lys Asn Pro
Ile Lys Pro Asn
Ile Leu Glu Pro
Ile Leu Pro Glu
Ile Asn Lys Pro
Ile Asn Pro Lys
Ile Pro Glu Ile
Ile Pro Glu Leu
Ile Pro Ile Glu
Ile Pro Lys Asn
Ile Pro Leu Glu
Ile Pro Asn Lys
Lys Ile Asn Pro
Lys Ile Pro Asn
Lys Leu Asn Pro
Lys Leu Pro Asn
Lys Asn Ile Pro
Lys Asn Leu Pro
Lys Asn Pro Ile
Lys Asn Pro Leu
Lys Pro Ile Asn
Lys Pro Leu Asn
Lys Pro Asn Ile
Lys Pro Asn Leu
Lys Pro Gln Val
Lys Pro Val Gln
Lys Gln Pro Val
Lys Gln Val Pro
Lys Val Pro Gln
Lys Val Gln Pro
Leu Glu Ile Pro
Leu Glu Leu Pro
Leu Glu Pro Ile
Leu Glu Pro Leu
Leu Ile Glu Pro
Leu Ile Pro Glu
Leu Lys Asn Pro
Leu Lys Pro Asn
Leu Leu Glu Pro
Leu Leu Pro Glu
Leu Asn Lys Pro
Leu Asn Pro Lys
Leu Pro Glu Ile
Leu Pro Glu Leu
Leu Pro Ile Glu
Leu Pro Lys Asn
Leu Pro Leu Glu
Leu Pro Asn Lys
Asn Ile Lys Pro
Asn Ile Pro Lys
Asn Lys Ile Pro
Asn Lys Leu Pro
Asn Lys Pro Ile
Asn Lys Pro Leu
Asn Leu Lys Pro
Asn Leu Pro Lys
Asn Pro Ile Lys
Asn Pro Lys Ile
Asn Pro Lys Leu
Asn Pro Leu Lys
Pro Ala Gln Arg
Pro Ala Arg Gln
Pro Glu Ile Ile
Pro Glu Ile Leu
Pro Glu Leu Ile
Pro Glu Leu Leu
Pro Ile Glu Ile
Pro Ile Glu Leu
Pro Ile Ile Glu
Pro Ile Lys Asn
Pro Ile Leu Glu
Pro Ile Asn Lys
Pro Lys Ile Asn
Pro Lys Leu Asn
Pro Lys Asn Ile
Pro Lys Asn Leu
Pro Lys Gln Val
Pro Lys Val Gln
Pro Leu Glu Ile
Pro Leu Glu Leu
Pro Leu Ile Glu
Pro Leu Lys Asn
Pro Leu Leu Glu
Pro Leu Asn Lys
Pro Asn Ile Lys
Pro Asn Lys Ile
Pro Asn Lys Leu
Pro Asn Leu Lys
Pro Gln Ala Arg
Pro Gln Lys Val
Pro Gln Arg Ala
Pro Gln Val Lys
Pro Arg Ala Gln
Pro Arg Gln Ala
Pro Val Lys Gln
Pro Val Gln Lys
Gln Ala Pro Arg
Gln Ala Arg Pro
Gln Lys Pro Val
Gln Lys Val Pro
Gln Pro Ala Arg
Gln Pro Lys Val
Gln Pro Arg Ala
Gln Pro Val Lys
Gln Arg Ala Pro
Gln Arg Pro Ala
Gln Val Lys Pro
Gln Val Pro Lys
Arg Ala Pro Gln
Arg Ala Gln Pro
Arg Pro Ala Gln
Arg Pro Gln Ala
Arg Gln Ala Pro
Arg Gln Pro Ala
Val Lys Pro Gln
Val Lys Gln Pro
Val Pro Lys Gln
Val Pro Gln Lys
Val Gln Lys Pro
Val Gln Pro Lys
Methyl lucidenate F
Withanolide
A withanolide that is 5,6:22,26-diepoxyergosta-2,24-diene-1,26-dione substituted by hydroxy groups at positions 4 and 22 (the 4beta,5beta,6beta,22R stereoisomer). Isolated from Tubocapsicum anomalum and Withania somnifera, it exhibits cytotoxic activity. Withanolides, which are extracted from Withania somnifera, are employed in the treatment of arthritis and are known to be potent inhibitors of angiogenesis, inflammation and oxidative stress. Withanolides can indeed inhibit the activation of NF-κB and NF-κB-regulated gene expression, which could explain their anti-arthritic actions. W. somnifera root powder has suppressive effect on arthritis by reducing amplification and propagation of the inflammatory response, without causing any gastric damage. (PMID: 17475558, 3248848, 17084827) [HMDB]
Withanolide
Withalongolide B
A withanolide that is 27-deoxywithaferin A substituted by a hydroxy group at position 19. Isolated from Physalis longifolia, it exhibits antineoplastic activity.
bis(2-methacryloxyethyl)-n,n-1,9-nonylene biscarbamate
butyl prop-2-enoate,ethenyl acetate,2-ethylhexyl prop-2-enoate,prop-2-enoic acid
1,1,3,3,3,3-hexamethylindodicarbocyanine tetrafluoroborate, borate(1-), tetrafluoro-, 2-[5-(1,3-dihydro-1,3,3-trimethyl-2h-indol-2-ylidene)-1,4-pentadienyl]-1,3,3-trimethyl-3h-indolium
2-[3-[1-(5-Carboxypentyl)-1,3-dihydro-3,3-dimethyl-2H-indol-2-ylidene]-1-propenyl]-1-ethyl-3,3-dimethyl-3H-indolium inner salt
Methyl [(2S)-3-methyl-1-oxo-1-{(2S)-2-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]-1-pyrrolidinyl}-2-butanyl]carbamate
TERT-BUTYL 3,5-BIS(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRROLO[2,3-B]PYRIDINE-1-CARBOXYLATE
Methanone, ((3S,4R)-4-(2,4-difluorophenyl)-1-(1,1-dimethylethyl)-3-pyrrolidinyl)((3R,5S)-4-hydroxy-3,5-dimethyl-4-phenyl-1-piperidinyl)-
Bacilysocin
A carboxylic ester resulting from the formal condensation of the carboxylic acid group of 12-methyltetradecanoic acide with one of the primary alcoholic hydroxy groups of glycerophosphoglycerol. An antibiotic obtained from Bacillus subtilis 168, it has particular activity against certain fungi. The stereochemistries of the hydroxy groups at positions C-2 and C-2 and the methyl group at position C-12 have not been determined.
4-{(4-anilinonaphthalen-1-yl)[4-(dimethylamino)phenyl]methylidene}-N,N-dimethylcyclohexa-2,5-dien-1-iminium
Bazedoxifene
G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03X - Other sex hormones and modulators of the genital system > G03XC - Selective estrogen receptor modulators D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D020847 - Estrogen Receptor Modulators C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D050071 - Bone Density Conservation Agents C1892 - Chemopreventive Agent
[1-(Furan-3-yl)-8-hydroxy-4b,7,7,10a,12a-pentamethyl-3-oxo-1,5,6,6a,8,9,10,10b,11,12-decahydronaphtho[2,1-f]isochromen-5-yl] acetate
(1S,2S,4S,5R,10R,14S,15S,18S)-15-[(1R)-1-[(2R)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-1-hydroxyethyl]-5-hydroxy-10,14-dimethyl-3-oxapentacyclo[9.7.0.02,4.05,10.014,18]octadec-7-en-9-one
Tubocapsanolide F
A withanolide that is 5,6:22,26-diepoxyergosta-2,24-diene-1,26-dione substituted by hydroxy groups at positions 4 and 17 (the 4beta,5beta,6beta,22R stereoisomer). Isolated from Tubocapsicum anomalum, it exhibits cytotoxic activity.
4-[4-[[[1-(2-methylpropyl)-3-pyrrolidinyl]methylamino]-oxomethyl]-3-oxo-1H-isoindol-2-yl]-1-piperidinecarboxylic acid ethyl ester
(2R,3S,4S,4aR,5aS,6aR,8R,9S,11S,12aS,13aR,14S,15S,15aS)-9-(hydroxymethyl)-3,4,11,14-tetramethyloctadecahydro-3H-spiro[furan-2,2-pyrano[2,3:6,7]oxepino[2,3:5,6]pyrano[3,2-b]oxocine]-8,15-diol
1-(2-methoxyphenyl)-3-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-methoxyphenyl)-3-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-methoxyphenyl)-3-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-methoxyphenyl)-3-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-methoxyphenyl)-3-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-methoxyphenyl)-3-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-methoxyphenyl)-3-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-methoxyphenyl)-3-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-methoxyphenyl)-3-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-methoxyphenyl)-3-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
(1R)-1-(hydroxymethyl)-7-methoxy-2-[4-oxanyl(oxo)methyl]-N-propan-2-yl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
(1S)-N-cyclopentyl-1-(hydroxymethyl)-7-methoxy-1-(2-methoxy-1-oxoethyl)-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide
1-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-methoxyphenyl)urea
1-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-methoxyphenyl)urea
1-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-methoxyphenyl)urea
1-(2-methoxyphenyl)-3-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-methoxyphenyl)-3-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-methoxyphenyl)-3-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-methoxyphenyl)-3-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-methoxyphenyl)-3-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-methoxyphenyl)-3-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-methoxyphenyl)-3-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-methoxyphenyl)-3-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-methoxyphenyl)-3-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-methoxyphenyl)-3-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-methoxyphenyl)-3-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-methoxyphenyl)-3-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-methoxyphenyl)-3-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-methoxyphenyl)-3-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-methoxyphenyl)-3-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
(1S)-1-(hydroxymethyl)-7-methoxy-2-[4-oxanyl(oxo)methyl]-N-propan-2-yl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
(1R)-N-cyclopentyl-1-(hydroxymethyl)-7-methoxy-1-(2-methoxy-1-oxoethyl)-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide
(3aS,5aR,9bR)-5a,9-dimethyl-3-methylene-4,5,6,7,8,9b-hexahydro-3aH-benzo[g]benzofuran-2-one
(2S,6S,7S,9R,11R,12R,15R,16R)-6-hydroxy-15-[1-[(2S)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-2,16-dimethyl-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadec-4-en-3-one
(2S,6S,7S,9R,11R,15R,16R)-6-hydroxy-15-[1-[(2S)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-2,16-dimethyl-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadec-4-en-3-one
[3-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] pentadecanoate
[(2R)-1,1,2,3,3-pentadeuterio-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] pentadecanoate
[(2R)-1,1,3,3-tetradeuterio-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] pentadecanoate
2-[2-[3-(1-Methylethylamino)-2-hydroxypropyloxy]ethyl]-2,5,7,8-tetramethyl-3,4-dihydro-2H-1-benzopyran-6-carboxylic acid 3-pyridyl ester
(1s,2s,4s,5r,10r,11s,14r,15r,18s)-5-hydroxy-15-[(1s)-1-[(2r)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-10,14-dimethyl-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-en-9-one
3-hydroxy-3-isopropyl-6,8a-dimethyl-8-[(2-methylbut-2-enoyl)oxy]-1,2,3a,4,5,8-hexahydroazulen-4-yl 4-methoxybenzoate
(1r,2r,4s,6r,7r,10s,11r,15s,16r)-15-hydroxy-6-[(1s)-1-[(2r)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-7,11-dimethyl-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadec-13-en-12-one
15-[1-(4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-5,15-dihydroxy-10,14-dimethyl-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-en-9-one
15-{2-hydroxy-1-[5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl}-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-3-one
n-[3-ethyl-5,8-dihydroxy-3-methyl-7-(2-methylpropyl)-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-1-methylpyrrolidine-2-carboximidic acid
5-hydroxy-2,16-dimethyl-15-{1-methyl-8-methylidene-7-oxo-2,6-dioxabicyclo[3.3.1]nonan-4-yl}-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadecan-3-one
(6s)-6-[(1s)-1-[(1r,3ar,3br,9ar,9bs,11as)-1,3a-dihydroxy-9a,11a-dimethyl-9-oxo-2h,3h,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3,4-dimethyl-5,6-dihydropyran-2-one
(1s,2r,6s,7r,9r,11s,12s,14r,15r,16s)-15-[(1s)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-6,14-dihydroxy-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-3-one
(1r,2r,7r,10r,11s,14r,15r,16r)-16-(4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)-7,15-dihydroxy-10,14,16-trimethyl-17-oxapentacyclo[13.2.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]nonadec-4-en-9-one
(2s)-2-[(2r,3r,4s)-3-[(1e,3e,5e,7e,9e)-10-[(2r,5s,6s)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]undeca-1,3,5,7,9-pentaen-1-yl]-3,4-dimethyl-5-oxooxolan-2-yl]propanoic acid
3,3',4'-trihydroxy-4,5,5,10',14',16'-hexamethyl-18'-oxaspiro[oxolane-2,17'-pentacyclo[13.3.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane]-2'(11'),5',12'-trien-7'-one
6-[(1r)-1-[(1s,3as,5as,9ar,9bs,11ar)-3a,5a-dihydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,5h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3,4-dimethyl-5,6-dihydropyran-2-one
(6r)-6-[(1r)-1-[(1s,3ar,3br,6s,9ar,9bs,11ar)-3a,6-dihydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3,4-dimethyl-5,6-dihydropyran-2-one
(1r,3as,4r,8s,8as)-1-hydroxy-1-isopropyl-3a,6-dimethyl-8-{[(2e)-2-methylbut-2-enoyl]oxy}-2,3,4,7,8,8a-hexahydroazulen-4-yl 4-methoxybenzoate
15-hydroxy-6-{1-[5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl}-7,11-dimethyl-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadec-13-en-12-one
2-{[4-(5-hydroxy-3-methylpent-3-en-1-yl)-3,8-bis(hydroxymethyl)-4a,8-dimethyl-1,2,5,6,7,8a-hexahydronaphthalen-1-yl]oxy}oxane-3,4,5-triol
2-{3-[10-(5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl)undeca-1,3,5,7,9-pentaen-1-yl]-3,4-dimethyl-5-oxooxolan-2-yl}propanoic acid
(1s,2r,7s,9r,11s,12s,15r,16s)-15-hydroxy-15-[(1r,4r,5r,7s)-4-hydroxy-4,5-dimethyl-3-oxo-2-oxabicyclo[3.2.1]octan-7-yl]-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-3-one
(1s,2r,7r,9s,11r,14s,15s)-14-hydroxy-15-[(1s)-1-[(1s,2r,4s,6s)-2-hydroxy-1,6-dimethyl-3,7-dioxabicyclo[4.1.0]heptan-4-yl]ethyl]-2,15-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadeca-4,12(16)-dien-3-one
(20s,22r)-5α,27-dihydroxy-6α,7α-epoxy-1-oxo-witha-2,24-dienolide
{"Ingredient_id": "HBIN003477","Ingredient_name": "(20s,22r)-5\u03b1,27-dihydroxy-6\u03b1,7\u03b1-epoxy-1-oxo-witha-2,24-dienolide","Alias": "NA","Ingredient_formula": "C28H38O6","Ingredient_Smile": "CC1=C(C(=O)OC(C1)C(C)C2CCC3C2(C(CC4C3C5C(O5)C6(C4(C(=O)C=CC6)C)O)O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5879","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6α,7α-epoxy-5α,20β-dihydroxy-1-oxowitha-2,24-dienolide
{"Ingredient_id": "HBIN012189","Ingredient_name": "6\u03b1,7\u03b1-epoxy-5\u03b1,20\u03b2-dihydroxy-1-oxowitha-2,24-dienolide","Alias": "NA","Ingredient_formula": "C28H38O6","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7081","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
ajugin
{"Ingredient_id": "HBIN014987","Ingredient_name": "ajugin","Alias": "NA","Ingredient_formula": "C28H38O6","Ingredient_Smile": "CC1=C(C(=O)OC(C1)C2(C3(CCC4(C3(CCC5C4CC=C6C5(C(=O)CC(C6)O)C)C)O2)O)C)C","Ingredient_weight": "470.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "812","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "100982555","DrugBank_id": "NA"}